CTOR vs ESS · $105.2M cap vs P/E 31, rev $1.89B
Citius Oncology, Inc. (CTOR) versus Essex Property Trust Inc (ESS) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
CTOR does not have a complete income-statement cache yet.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
CTOR currently screens at market cap $105.2M. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Not investment advice. Open the CTOR and ESS stock pages for the full models.
Not investment advice.